169 related articles for article (PubMed ID: 31845230)
1. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.
Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F
Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.
Wang Y; Wu J; Xu J; Lin S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
Jansen MP; Sas L; Sieuwerts AM; Van Cauwenberghe C; Ramirez-Ardila D; Look M; Ruigrok-Ritstier K; Finetti P; Bertucci F; Timmermans MM; van Deurzen CH; Martens JW; Simon I; Roepman P; Linn SC; van Dam P; Kok M; Lardon F; Vermeulen PB; Foekens JA; Dirix L; Berns EM; Van Laere S
Mol Oncol; 2015 Jun; 9(6):1218-33. PubMed ID: 25771305
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer.
Wang YY; Li L; Zhao ZS; Wang HJ
World J Surg Oncol; 2013 Apr; 11():81. PubMed ID: 23548070
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer.
Hashemzadeh S; Arabzadeh AA; Estiar MA; Sakhinia M; Mesbahi N; Emrahi L; Ghojazadeh M; Sakhinia E
Med Oncol; 2014 Oct; 31(10):237. PubMed ID: 25234931
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
Watanabe T; Shiozawa M; Kimura Y; Hiroshima Y; Hashimoto I; Komori K; Watanabe H; Kano K; Fujikawa H; Aoyama T; Numata M; Yamada T; Tamagawa H; Ogata T; Yukawa N; Morinaga S; Rino Y; Masuda M; Miyagi Y; Oshima T
Anticancer Res; 2021 Apr; 41(4):2117-2122. PubMed ID: 33813422
[TBL] [Abstract][Full Text] [Related]
7. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
Li J; Yang Z; Huang S; Li D
Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
Ieta K; Tanaka F; Yokobori T; Kita Y; Haraguchi N; Mimori K; Kato H; Asao T; Inoue H; Kuwano H; Mori M
Int J Cancer; 2009 Aug; 125(4):926-31. PubMed ID: 19415750
[TBL] [Abstract][Full Text] [Related]
10. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
Coulson-Gilmer C; Humphries MP; Sundara Rajan S; Droop A; Jackson S; Condon A; Cserni G; Jordan LB; Jones LJ; Kanthan R; Di Benedetto A; Mottolese M; Provenzano E; Kulka J; Shaaban AM; Hanby AM; Speirs V
J Pathol Clin Res; 2018 Oct; 4(4):241-249. PubMed ID: 29956502
[TBL] [Abstract][Full Text] [Related]
11. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
Lin C; Sun L; Huang S; Weng X; Wu Z
Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
[TBL] [Abstract][Full Text] [Related]
12. STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
Wu J; Lai M; Shao C; Wang J; Wei JJ
Oncol Rep; 2015 Sep; 34(3):1494-502. PubMed ID: 26165228
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract][Full Text] [Related]
14. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.
Qie S; Sang N
J Exp Clin Cancer Res; 2022 May; 41(1):161. PubMed ID: 35501821
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of LRP16 gene in human breast cancer].
Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH
Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279
[TBL] [Abstract][Full Text] [Related]
16. mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers.
Yamamura J; Miyoshi Y; Tamaki Y; Taguchi T; Iwao K; Monden M; Kato K; Noguchi S
Cancer Sci; 2004 Nov; 95(11):887-92. PubMed ID: 15546506
[TBL] [Abstract][Full Text] [Related]
17. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.
Raulic S; Ramos-Valdes Y; DiMattia GE
J Endocrinol; 2008 Jun; 197(3):517-29. PubMed ID: 18492817
[TBL] [Abstract][Full Text] [Related]
18. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
Law AY; Wong CK
Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
[TBL] [Abstract][Full Text] [Related]
19. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.
Na SS; Aldonza MB; Sung HJ; Kim YI; Son YS; Cho S; Cho JY
Biochim Biophys Acta; 2015 Jun; 1854(6):668-76. PubMed ID: 25463045
[TBL] [Abstract][Full Text] [Related]
20. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
